Cargando...
Cancer immunotherapy: exploiting neoepitopes
The efficacy of cancer vaccines has long been hampered by insufficient definition of tumor-specific antigens. A recent study by Kreiter et al. published in Nature has provided a blueprint for a patient-tailored approach to develop individualized RNA vaccines.
Guardado en:
| Publicado en: | Cell Res |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4528051/ https://ncbi.nlm.nih.gov/pubmed/26032267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2015.66 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|